Skip to content
OI
Company

Updated:

Oxford Immunotec Global PLC

Oxford Immunotec Global PLC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001586049, and its reported...

Overview

Oxford Immunotec Global PLC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001586049, and its reported industry is In Vitro & In Vivo Diagnostic Substances. In 10-K filed on 2020-03-06, it reported annual revenue of USD 73,710,000; net income of USD -1,809,000; total assets of USD 235,252,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Oxford Immunotec Global PLC
Classification
Company
Industry (SIC)
2835 — In Vitro & In Vivo Diagnostic Substances
Headquarters
Abingdon, United Kingdom
Incorporated in
X0
Fiscal year end
December 31
SEC CIK
0001586049

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2019USD$73.7M-$1.8M$235.3M$181.3M—
FY2018USD$59.8M$120.8M$232.1M$192.8M—
FY2017USD$103.1M-$32.9M$144.2M$90.3M-$3.6M
FY2016USD$86.1M-$22.3M$124.0M$59.1M-$21.9M

Recent SEC filings

FormFiledPeriodFiling
SC 13G—SCHEDULE 13G
SC 13G—Form SC 13G
8-K8-K
8-K8-K
SC 13G—SCHEDULE 13G HOLDINGS REPORT
SC 13G—ENDURANT13GOXFD
SC 13G—OXFORD IMMUNOTEC GLOBAL SC 13G
SC 13G—Form SC 13G
SC 13D—SC 13D
8-KFORM 8-K
8-KFORM 8-K
10-QFORM 10-Q

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Oxford Immunotec Global PLC in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Oxford Immunotec Global PLC | Abingdon Company | Altss